These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 29528873)

  • 1. Relationship of Anticoagulant Therapy With Cognitive Impairment Among Patients With Atrial Fibrillation: A Meta-Analysis and Systematic Review.
    Cheng W; Liu W; Li B; Li D
    J Cardiovasc Pharmacol; 2018 Jun; 71(6):380-387. PubMed ID: 29528873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.
    Hirano T; Kaneko H; Mishina S; Wang F; Morita S
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time outside of therapeutic range in atrial fibrillation patients is associated with long-term risk of dementia.
    Jacobs V; Woller SC; Stevens S; May HT; Bair TL; Anderson JL; Crandall BG; Day JD; Johanning K; Long Y; Mallender C; Olson JL; Osborn JS; Weiss JP; Bunch TJ
    Heart Rhythm; 2014 Dec; 11(12):2206-13. PubMed ID: 25111326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Warfarin Anticoagulation and Incident Dementia in a Community-Based Cohort of Atrial Fibrillation.
    Madhavan M; Hu TY; Gersh BJ; Roger VL; Killian J; Weston SA; Graff-Radford J; Asirvatham SJ; Chamberlain AM
    Mayo Clin Proc; 2018 Feb; 93(2):145-154. PubMed ID: 29329798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Risk of Dementia With Direct Oral Anticoagulants Versus Warfarin Use in Patients With Non-valvular Atrial Fibrillation: A Systematic Review and Meta-analysis.
    Lee ZX; Ang E; Lim XT; Arain SJ
    J Cardiovasc Pharmacol; 2021 Jan; 77(1):22-31. PubMed ID: 33136766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboprophylaxis in atrial fibrillation and association with cognitive decline: systematic review.
    Moffitt P; Lane DA; Park H; O'Connell J; Quinn TJ
    Age Ageing; 2016 Nov; 45(6):767-775. PubMed ID: 27496936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and design of the impact of anticoagulation therapy on the Cognitive Decline and Dementia in Patients with Nonvalvular Atrial Fibrillation (CAF) Trial: A Vanguard study.
    Bunch TJ; Jacobs V; May H; Stevens SM; Crandall B; Cutler M; Day JD; Mallender C; Olson J; Osborn J; Weiss JP; Woller SC
    Clin Cardiol; 2019 May; 42(5):506-512. PubMed ID: 30937935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: A Systematic Review and Meta-Analysis.
    Pan KL; Singer DE; Ovbiagele B; Wu YL; Ahmed MA; Lee M
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28720644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the impact of warfarin time in therapeutic range on outcomes of patients with atrial fibrillation in Turkey: perspectives from the observational, prospective WATER Registry.
    Turk UO; Tuncer E; Alioglu E; Yuksel K; Pekel N; Ozpelit E; Vuran O; Tengiz I
    Cardiol J; 2015; 22(5):567-75. PubMed ID: 26100825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability of INR and its relationship with mortality, stroke, bleeding and hospitalisations in patients with atrial fibrillation.
    Lind M; Fahlén M; Kosiborod M; Eliasson B; Odén A
    Thromb Res; 2012 Jan; 129(1):32-5. PubMed ID: 21851969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-Analysis of Safety and Efficacy of Direct Oral Anticoagulants Versus Warfarin According to Time in Therapeutic Range in Atrial Fibrillation.
    Lee JJ; Ha ACT; Dorian P; Verma M; Goodman SG; Friedrich JO
    Am J Cardiol; 2021 Feb; 140():62-68. PubMed ID: 33189659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation.
    Clarkesmith DE; Pattison HM; Lane DA
    Cochrane Database Syst Rev; 2013 Jun; (6):CD008600. PubMed ID: 23736948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving quality measurement for anticoagulation: adding international normalized ratio variability to percent time in therapeutic range.
    Razouki Z; Ozonoff A; Zhao S; Jasuja GK; Rose AJ
    Circ Cardiovasc Qual Outcomes; 2014 Sep; 7(5):664-9. PubMed ID: 25185245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral anticoagulants and risk of dementia: A systematic review and meta-analysis of observational studies and randomized controlled trials.
    Mongkhon P; Naser AY; Fanning L; Tse G; Lau WCY; Wong ICK; Kongkaew C
    Neurosci Biobehav Rev; 2019 Jan; 96():1-9. PubMed ID: 30391408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the effects of NOAC and VKA therapy on the incidence of dementia in patients with atrial fibrillation: A systematic review and meta-analysis.
    Wang W; Fan W; Su Y; Hong K
    Clin Cardiol; 2023 Aug; 46(8):866-876. PubMed ID: 37366141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Causes of Ischemic Stroke in Patients with Non-Valvular Atrial Fibrillation.
    Nakamura A; Kuroda J; Ago T; Hata J; Matsuo R; Arakawa S; Kuwashiro T; Yasaka M; Okada Y; Kitazono T; Kamouchi M;
    Cerebrovasc Dis; 2016; 42(3-4):196-204. PubMed ID: 27111222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Frequency of use of oral vitamin K antagonists in patients with atrial fibrillation and cognitive function disturbances].
    Gorzelak P; Zyzak S; Krewko Ł; Mozdzan M; Broncel M
    Pol Merkur Lekarski; 2014 May; 36(215):302-6. PubMed ID: 24964505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral anticoagulant and reduced risk of dementia in patients with atrial fibrillation: A population-based cohort study.
    Mongkhon P; Fanning L; Lau WCY; Tse G; Lau KK; Wei L; Kongkaew C; Wong ICK
    Heart Rhythm; 2020 May; 17(5 Pt A):706-713. PubMed ID: 31931172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction.
    Szummer K; Gasparini A; Eliasson S; Ärnlöv J; Qureshi AR; Bárány P; Evans M; Friberg L; Carrero JJ
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28249846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-vitamin K antagonist oral anticoagulants compared with warfarin at different levels of INR control in atrial fibrillation: A meta-analysis of randomized trials.
    Carmo J; Ferreira J; Costa F; Carmo P; Cavaco D; Carvalho S; Morgado F; Adragão P; Mendes M
    Int J Cardiol; 2017 Oct; 244():196-201. PubMed ID: 28679480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.